How harmful algae in the air can affect lung health
Official title: Atmospheric transformation of harmful cyanobacterial algae and novel mechanisms of pulmonary toxicity
Funded at University of South Carolina at Columbia · NIH-10948382 · Data updated 2026-11-12
This study is looking at how breathing in toxins from harmful algae can affect lung health, especially for people living near lakes or rivers with these algae, to help us understand the risks better.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of South Carolina at Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $200,230 |
| NIH project number | 1R21ES036635-01 |
| Project ID | NIH-10948382 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals living near freshwater bodies affected by harmful algal blooms, particularly those experiencing respiratory symptoms.
✕Less likely to help
Patients who do not live in proximity to freshwater bodies with harmful algal blooms may not receive direct benefits from this research.
What this research studies
This research investigates the effects of harmful algal blooms (HABs) on respiratory health, particularly focusing on the inhalation of toxins produced by cyanobacteria. It aims to understand how these toxins transform in the atmosphere and their potential subacute health implications, especially for individuals living near affected water bodies. By studying animal and cell models, the research seeks to uncover the immune responses triggered by inhaled algal toxins, which have not been thoroughly explored in previous studies. The findings could provide insights into the risks associated with airborne exposure to these harmful algae.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and management of respiratory health risks associated with harmful algal blooms.
How similar studies have gone: While there is limited research on the inhalation of algal toxins, studies have shown significant health impacts from waterborne exposure, indicating a need for further investigation into airborne exposure.
Where this research is happening
-
University of South Carolina at Columbia
Columbia, United States Active
Researchers
- Principal investigator: Sabo-Attwood, Tara L — University of South Carolina at Columbia
- Study coordinator: Sabo-Attwood, Tara L
Related research
Other NIH-funded projects on the same topics.
-
Understanding how altered citric acid cycle fuels may help kids and adults with Complex I mitochondrial disease
A small study will look at how changes in the citric acid cycle and a molecule called 2-HG affect people with Complex I–related mitochondrial disease, to identify potential new treatment strategies.
-
Confidential social network referrals to boost HIV testing
A new approach uses anonymous mobile-text referrals to encourage people at risk to get HIV tested.
-
How brain cells move and translate messages to stay healthy in Alzheimer’s and related dementias
A study to understand how RNA binding proteins affect the way brain cells transport and translate messages, which may influence Alzheimer’s and related dementias.
-
Adolescent neurobehavioral outcomes after early nutrition: follow-up of a Bangladeshi trial
This project follows up on children who received nutrient-rich supplements in early life to see how it affects their brain development and behavior during adolescence.
-
Adolescent neurobehavioral outcomes after early-life nutrition in a Bangladeshi cohort
This project follows up teens who were part of an early-life nutrition trial to see how their development and behavior look years later.
-
Brain-boosting blood pressure pathways as a treatment to prevent and treat HAND in aging people with HIV
This research tests whether medicines that affect the brain’s blood-vessel system can protect brain cells and reduce inflammation in people aging with HIV who have cognitive problems.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.